Correlation Between Krystal Biotech and Elicio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Elicio Therapeutics, you can compare the effects of market volatilities on Krystal Biotech and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Elicio Therapeutics.

Diversification Opportunities for Krystal Biotech and Elicio Therapeutics

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Krystal and Elicio is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Krystal Biotech and Elicio Therapeutics

Given the investment horizon of 90 days Krystal Biotech is expected to generate 1.44 times less return on investment than Elicio Therapeutics. But when comparing it to its historical volatility, Krystal Biotech is 1.26 times less risky than Elicio Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  431.00  in Elicio Therapeutics on August 30, 2024 and sell it today you would earn a total of  74.00  from holding Elicio Therapeutics or generate 17.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Krystal Biotech  vs.  Elicio Therapeutics

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Krystal Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Elicio Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Krystal Biotech and Elicio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and Elicio Therapeutics

The main advantage of trading using opposite Krystal Biotech and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.
The idea behind Krystal Biotech and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device